Detalhe da pesquisa
1.
Emergence, spread and characterisation of the SARS-CoV-2 variant B.1.640 circulating in France, October 2021 to February 2022.
Euro Surveill
; 28(22)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261732
2.
Field Epidemiology and Public Health Microbiology training: capturing the alumni perspectives of the training's impact.
Euro Surveill
; 28(36)2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676148
3.
Analysis of the HbpA Protein from Corynebacterium diphtheriae Clinical Isolates and Identification of a Putative Hemoglobin-Binding Site on HbpA.
J Bacteriol
; 204(12): e0034922, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346227
4.
Evidence of Transmission and Circulation of Deltacron XD Recombinant Severe Acute Respiratory Syndrome Coronavirus 2 in Northwest France.
Clin Infect Dis
; 75(10): 1841-1844, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535770
5.
Association of Phylogenomic Relatedness among Neisseria gonorrhoeae Strains with Antimicrobial Resistance, Austria, 2016-2020.
Emerg Infect Dis
; 28(8): 1694-1698, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876744
6.
Assessing the Genetic Diversity of Austrian Corynebacterium diphtheriae Clinical Isolates, 2011 to 2019.
J Clin Microbiol
; 59(3)2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268541
7.
Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.
PLoS Pathog
; 14(11): e1007430, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419076
8.
Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France.
Vaccine
; 41(17): 2754-2760, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964001
9.
Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France.
Vaccine
; 41(38): 5490-5493, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541823
10.
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.
EClinicalMedicine
; 48: 101455, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35611065
11.
Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020.
Microbiol Spectr
; 10(3): e0275721, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678576
12.
Rapid investigation of BA.4/BA.5 cases in France.
Front Public Health
; 10: 1006631, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311621
13.
Tracking the Origin of Austrian Human Brucellosis Cases Using Whole Genome Sequencing.
Front Med (Lausanne)
; 8: 635547, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718408
14.
Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq.
Nat Commun
; 12(1): 3132, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035246
15.
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.
Commun Biol
; 4(1): 27, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398113
16.
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Lancet Glob Health
; 9(4): e469-e478, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740408
17.
Draft Genome Sequences of Six Corynebacterium ulcerans Strains Isolated from Humans and Animals in Austria, 2013 to 2019.
Microbiol Resour Announc
; 9(36)2020 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883799
18.
Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE).
Travel Med Infect Dis
; 36: 101557, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978611
19.
Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus.
Viruses
; 11(3)2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901952
20.
Immune parameters and outcomes during Ebola virus disease.
JCI Insight
; 4(1)2019 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626757